BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:07 PM
 | 
Jul 26, 2007
 |  BC Extra  |  Top Story

Amgen beats Street

AMGN reported 2Q07 adjusted diluted EPS of $1.12, beating by $0.06 the Street consensus of $1.06 and up 7% from $1.05 in 2Q06. Sales were up 3% to $3.6 billion from $3.5 billion in the same period last year.

Second quarter sales of Aranesp for anemia were $949 million, down 10% from $1.1 billion in 2Q06 and down 5%...

Read the full 284 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >